$SCAI (Surgical Care Affiliates, Inc.)

$SCAI {{ '2016-09-13T19:00:48+0000' | timeago}} • Announcement

Surgical facilities operator $SCAI has partnered with Executive Surgery Center effective August 1, 2016. Executive Surgery Center is an outpatient surgery center located in Texas which offers its community a safe and convenient alternative to hospital-based surgery. This partnership establishes $SCAI's presence in the Houston market.

$THC {{ '2018-01-05T17:28:17+0000' | timeago}} • Announcement

$THC and St. Luke’s Hospital, an independent, non-profit healthcare provider, have entered into a definitive agreement for St. Luke’s to purchase Des Peres Hospital as well as Tenet-owned physician practices and other hospital-affiliated operations in St. Louis. The transaction is expected to be completed early in 2018.

$THC {{ '2018-01-04T22:16:28+0000' | timeago}} • Announcement

$THC and Baylor Scott & White Health plan to restructure their JV arrangements for three North Texas hospitals by spring of 2018. Baylor Scott & White will acquire $THC’s minority interest in Baylor Scott & White - Centennial and Baylor Scott & White - Lake Pointe. Baylor Scott & White - Sunnyvale will become part of Texas Health Ventures Group.

$THC {{ '2017-12-26T17:43:20+0000' | timeago}} • Announcement

$THC and Baylor Scott & White Health have agreed to sell Baylor Scott & White Medical Center - White Rock, a 218-bed hospital located in Dallas, Texas, to Pipeline Health, LLC. The hospital is part of a JV partnership with Baylor Scott & White Health, in which $THC is the minority owner. The transaction is expected to be completed in 1Q18.

$THC {{ '2017-12-19T13:06:16+0000' | timeago}} • Announcement

For FY18, $THC expects its net income to be in the range of $65-70MM with EPS of about $0.63-0.68. Adj. EPS is expected to be about $1.07-1.36. Net operating revenue is expected to be about $17.8-18.2Bil.

$THC {{ '2017-12-19T13:04:06+0000' | timeago}} • Announcement

$THC said it would explore a sale of its subsidiary Conifer. The company expects to make a decision regarding the sale during the first half of 2018. Goldman, Sachs & Co. LLC as its financial advisor and Kirkland & Ellis LLP are the legal advisor.

$THC {{ '2017-12-19T13:00:29+0000' | timeago}} • Announcement

$THC has increased the size of its previously announced cost reduction initiative by  $100MM. The company now expects to achieve $200MM of annualized savings by the end of 2018. $THC has also started a process to refresh the composition of its BoD. The board currently consists of 12 directors.

$SPPI {{ '2017-12-18T12:56:05+0000' | timeago}} • Announcement

Biotechnology firm $SPPI has terminated Rajesh Shrotriya from the post of CEO. Joseph Turgeon, President and COO, has been assigned the additional role of CEO. Stuart Krassner, who serves as a director, was named Chairman of the Board. EVP and Chief Commercial Officer Thomas Riga has been appointed as the COO. The changes are effective immediately.

$THC {{ '2017-11-27T16:36:45+0000' | timeago}} • Announcement

$THC announced that Sandi Karrmann has been named SVP and Chief Human Resources Officer, effective immediately. Ms. Karrmann replaces Robb Webb, who has retired from the company. She will report directly to Ron Rittenmeyer, Executive Chairman and CEO.

$PDCO {{ '2017-11-21T17:10:59+0000' | timeago}} • Announcement

When announcing 2Q18 results, $PDCO cut down its previously announced FY18 outlook. Patterson now expects GAAP EPS to be $1.67-1.77 compared with the previous outlook of $1.90-2.05. Non-GAAP EPS expectation was also trimmed to $2.00-2.10 band from the earlier range of $2.25-2.40.

$PDCO {{ '2017-11-21T17:09:44+0000' | timeago}} • Announcement

$PDCO said that its 2Q18 profit was impacted by the strategic actions taken by the company, market conditions and the impact of hurricanes. Net income dropped 12% to $40MM or $0.43 per share, while sales slipped 2.3% to $1.4Bil. Adjusted earnings slide 9% to $0.51 per share.

$PDCO {{ '2017-11-21T15:31:11+0000' | timeago}} • Infographic

$PDCO Patterson Companies, Inc. Earnings AlphaGraphic: Q2 2018 Highlights

$EVHC {{ '2017-11-15T19:08:37+0000' | timeago}} • Infographic

$EVHC Envision Healthcare Holdings, Inc. Earnings AlphaGraphic: Q3 2017 Highlights

$HCA {{ '2017-11-01T18:32:50+0000' | timeago}} • Infographic

$HCA HCA Healthcare, Inc. Earnings AlphaGraphic: Q3 2017 Highlights

$HCA {{ '2017-10-19T13:19:20+0000' | timeago}} • Announcement

$HCA updated its 2017 guidance. Revenues are expected to be $43-44Bil and diluted EPS is expected to be $6.45-6.70. Adjusted EBITDA is expected to be $8-8.15Bil while Capex is expected to be approx. $3Bil.

$HCA {{ '2017-10-19T13:19:05+0000' | timeago}} • Announcement

$HCA announced preliminary 3Q17 results. Revenues are expected to be approx. $10.696Bil vs. $10.270Bil in 3Q16. Net income attributable to HCA Healthcare, Inc. is expected to approximate $426MM or $1.15 per share compared to $618MM or $1.59 per share in 3Q16. Adjusted EBITDA is expected to approximate $1.776Bil.

$CYH {{ '2017-10-02T11:51:11+0000' | timeago}} • Announcement

$CYH completed the sale of Weatherford Regional Medical Center in Weatherford, Texas, and its associated assets to subsidiaries of $HCA, effective October 1, 2017.

$SPPI {{ '2017-09-29T12:00:08+0000' | timeago}} • Announcement

Biotechnology firm $SPPI said it issued an aggregate of about 9.3MM shares under an offering program. The company intends to use the proceeds from the offering, about $90MM, to further its drug development pipeline and to provide additional flexibility to capital structure.

$PDCO {{ '2017-09-19T21:59:10+0000' | timeago}} • Announcement

$PDCO's BoD declared a quarterly cash dividend of $0.26 per share. The dividend will be payable on, or about, Oct. 27, 2017, to shareholders of record as of the close of business on Oct. 13, 2017.

$EVHC {{ '2017-09-19T12:30:35+0000' | timeago}} • Announcement

As part of $EVHC's organizational changes, Karey Witty, a veteran healthcare executive, has been appointed to the new role of EVP and COO, effective Oct 2, 2017. Kevin Eastridge, currently CAO, will succeed Claire Gulmi as CFO, effective same day.

$EVHC {{ '2017-09-19T12:24:50+0000' | timeago}} • Announcement

$EVHC announced the authorization of a program to repurchase up to $250MM of its common stock, which represents approx 4% of its current market capitalization.

Recent Transcripts

PDCO (Patterson Companies, Inc.)
Tuesday, November 21 2017 - 3:00pm
CORI (Corium International, Inc.)
Thursday, November 16 2017 - 10:00pm
RDNT (RadNet, Inc.)
Thursday, November 9 2017 - 3:30pm
SGRY (Surgery Partners, Inc.)
Thursday, November 9 2017 - 1:30pm
CGIX (Cancer Genetics, Inc.)
Thursday, November 9 2017 - 1:30pm
STAA (STAAR Surgical Company)
Wednesday, November 8 2017 - 9:30pm
MSON (Misonix, Inc.)
Tuesday, November 7 2017 - 9:30pm
THC (Tenet Healthcare Corp.)
Tuesday, November 7 2017 - 3:00pm
CORT (Corcept Therapeutics Incorporated)
Thursday, November 2 2017 - 9:00pm
SPPI (Spectrum Pharmaceuticals, Inc.)
Thursday, November 2 2017 - 8:30pm
EVHC (Envision Healthcare Holdings, Inc.)
Wednesday, November 1 2017 - 12:30pm
HCA (HCA Holdings, Inc.)
Tuesday, October 31 2017 - 2:00pm
PDCO (Patterson Companies, Inc.)
Thursday, August 24 2017 - 2:00pm
MSON (Misonix, Inc.)
Tuesday, August 22 2017 - 8:30pm
CGIX (Cancer Genetics, Inc.)
Monday, August 14 2017 - 9:00pm
SGRY (Surgery Partners, Inc.)
Wednesday, August 9 2017 - 12:30pm
RDNT (RadNet, Inc.)
Tuesday, August 8 2017 - 2:30pm
THC (Tenet Healthcare Corp.)
Tuesday, August 8 2017 - 2:00pm
EVHC (Envision Healthcare Holdings, Inc.)
Tuesday, August 8 2017 - 12:30pm
CORI (Corium International, Inc.)
Thursday, August 3 2017 - 9:00pm

AlphaGraphics you may like